U.S. farmers struggling with slumping incomes and depressed grain prices have been switching to cheaper generic pesticides ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced this week that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug ...

Swiss generic and biosimilar medicines major Sandoz today announced that the European Commission (EC) has granted marketing ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced this week that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year.

On this episode of Not So Different, we discuss the GRx+Biosims conference, which included discussions on data transparency, ...

Make Good, a new musical about the Post Office Scandal inspired by sub-postmasters’ interviews and performed with a community ...

Bayer AG (BAYRY) reports strong performance in Pharmaceuticals and Consumer Health, while facing headwinds in Crop Science ...

Generic Xarelto entry in various territories ... Considerable uncertainty regarding Bayer's glyphosate and PCB litigation is likely to continue for at least a couple of years.

Indian markets are abuzz with a singular refrain. Donald Trump's Presidency of the United States is set to open new ...

Swiss Re has reported a net income of $2.2bn for the first nine months of 2024, a 10.5% decrease from the same period last ...